Nick Goeden

Chief Science Officer

Asymptote Genetic Medicines
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Nick Goeden is the Chief Science Officer at Asymptote Genetic Medicines in the United States. His research focuses on adeno-associated viral (AAV) vectors and their applications in gene transfer, particularly within the non-human primate brain and nervous system. He has contributed to numerous publications that explore advancements in AAV technology and its implications for therapeutic delivery, as well as the use of ketamine infusion in critical care settings.

Articles (6)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (4)

Min Jee Jang

Assistant Professor

University of Illinois at Urbana-Champaign

UNITED STATES
View details

Qi Wang

University of Minnesota

UNITED STATES
View details

Katherine Ferrara

Professor

Stanford University

UNITED STATES
View details

EDUARDO A. SILVA

Associated Professor (with Tenure)

University of California, Davis

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.